Registration - In-house Corporation

Becton Dickinson Canada Inc / Ivy Parks, President

Registration Information

In-house Corporation name: Becton Dickinson Canada Inc
Responsible Officer Name: Ivy Parks, President
Responsible Officer Change History
Initial registration start date: 2017-09-07
Registration status: Active
Registration Number: 951016-360496

Associated Communications

Total Number of Communication Reports: 16

Monthly communication reports in the last 6 months: 7

Version 18 of 20 (2025-01-20 to 2026-03-27)

Registration versions:

Version 18 of 20 (2025-01-20 to 2026-03-27)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Economic Development, Foreign Affairs, Government Procurement, Health, Industry, International Relations, International Trade, National Security/Security, Science and Technology	Canadian-United States-Mexico Agreement (CUSMA) with respect to provisions relating to medical devices and technologies	Policies or Program, Regulation, Legislative Proposal, Bill or Resolution
Budget, Federal-Provincial Relations, Government Procurement, Health, Industry	Discuss policies around healthcare system resiliency, infection prevention, medication errors, women's health, and health equity	Regulation, Policies or Program
Economic Development, Federal-Provincial Relations, Government Procurement, Health, Industry, Science and Technology, Taxation and Finance	Federal budget with respect to medical technology and device innovation and adoption, support and delivery of new models of care, equitable healthcare access, women’s health, and investments in long-term care and home care	Legislative Proposal, Bill or Resolution
Economic Development, Government Procurement, Health, Industry, Science and Technology	Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector	Policies or Program
Economic Development, Health, Industry, Research and Development, Science and Technology	Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes.	Policies or Program
Economic Development, Government Procurement, Health, Industry, International Trade, Research and Development, Science and Technology	Federal life sciences strategy with respect to global value chain and supply chain management and investment towards medical technology manufacturing and export.	Regulation, Legislative Proposal, Bill or Resolution, Policies or Program
Federal-Provincial Relations, Health, Industry	Federal life sciences strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and diagnostic testing.	Policies or Program
Health, Industry, Science and Technology	Regulations under the Food and Drugs Act, including the Medical Devices Regulation, with respect to the approval of medical technologies	Regulation

Subject matter details added through monthly communication reports
Subject matters	Details	Categories	Added date
Budget, Federal-Provincial Relations, Government Procurement, Health, Industry, Taxation and Finance	Discuss policies around healthcare system resiliency, health system planning, infection prevention, medication errors, women's health, and health equity	Policies or Program, Regulation	2026-04-06
Economic Development, Federal-Provincial Relations, Foreign Affairs, Health, Industry, Taxation and Finance	Federal life sciences strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, health system planning and resilience.	Policies or Program	2026-04-06

Communication Techniques

Written communication
Oral communication

Government Institutions

Canadian Institutes of Health Research (CIHR)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Invest in Canada Hub
Public Health Agency of Canada (PHAC)
Public Services and Procurement Canada (PSPC)

Government institutions added through a monthly communication report

Finance Canada (FIN)

In-house Corporation Details

Description of activities

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and increase access to care through new models of healthcare delivery.

Responsible officer name and position during the period of this registration

Ivy Parks, President

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
2100 Derry Road West
Mississauga, ON L5N 0B3
Canada

Telephone number: 905-288-6000

Parent Company Information

Becton, Dickinson and Company
- 1 Becton Drive
  Franklin Lakes, NJ 07417
  United States of America

Subsidiary Beneficiary Information

Becton Dickinson Canada Inc does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Ivy Parks, President | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Enoch Owusu, Director of Regulatory Affairs | No public offices held
Robyn Saccon, Vice President, Public Affairs | No public offices held

Becton Dickinson Canada Inc

The following names have been used on or after July 2, 2008

Name	From	To
Becton Dickinson Canada Inc	2017-09-07	current

Becton Dickinson Canada Inc

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Ivy Parks	2021-10-04	Current
Gregory Miziolek	2019-02-11	2021-10-04
Stephen Gundersen	2017-09-07	2019-02-11

Date Modified:: 2026-05-11

Search and menus

Language selection

Registration - In-house Corporation

Becton Dickinson Canada Inc / Ivy Parks, President

Registration Information

Associated Communications

Version 18 of 20 (2025-01-20 to 2026-03-27)

Version 18 of 20 (2025-01-20 to 2026-03-27)

Subject Matter Details

Communication Techniques

Government Institutions

Government institutions added through a monthly communication report

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties